Skip to main content
. 2019 Apr 10;10:735. doi: 10.3389/fimmu.2019.00735

Figure 3.

Figure 3

FcγRIIIa expression on NK cell subsets in HIV-1 uninfected and HIV-1 infected individuals matched for FCGR genetic variants. (A) Gating strategy for defining four NK cell subsets: 1. CD56brightFcγRIIIadim/neg, 2. CD56dimFcγRIIIabright, 3. CD56dimFcγRIIIadim/neg, and 4. CD56negFcγRIIIabright; (B) Comparison of NK cell subsets between HIV-1 uninfected and infected individuals; (C) FcγRIIIa surface density on FcγRIIIabright NK cell subsets; (D) ADCC activity of NK cells at a target-to-effector cell ratio of 10:1 with isolated IgG pooled from HIV-1 study participants; (E) Median ADCC responses for individuals homozygous for the FcγRIIIa-158F allele and individuals bearing at least one FcγRIIIa-158V allele; (F) Correlation analysis between demographic, clinical, phenotypic and functional variables in HIV-1 uninfected and HIV-1 infected individuals (***P < 0.001; **P < 0.01; *P < 0.05).